Skip to main content
. Author manuscript; available in PMC: 2016 Apr 15.
Published in final edited form as: Cancer. 2014 Dec 23;121(8):1223–1230. doi: 10.1002/cncr.29175

Table 3.

Baseline and Treatment ECG

n=21
Baseline
  Normal 17 (81.0%)
  Abnormal 4 (19.0%)
1–2 Hours Post first dose ECG, within cycle
  Normal 54 (53.5%)
  Abnormal 47 (46.5%)
1–2 Hour Post second dose ECG, within cycle
  Normal 17 (73.9%)
  Abnormal 6 (26.1%)
Baseline QTc Interval (msec) (n, mean (SD), median, range) 21, 425.1 (15.0), 423, 396–446
Pre-dose QTc Interval (msec), performed in triplicate (n, mean (SD), median, range) 133, 428.3 (18.1), 427, 388–474
1–2 Hour Post first dose QTc Interval (msec), within cycle (n, mean (SD), median, range) 101, 436.5 (18.6), 438, 399–484
1–2 Hours Post second dose QTc Interval (msec), within cycle (n, mean (SD), median, range) 23, 427.3 (18.8), 431, 391–458